Dr. Yim is a pediatric hematology-oncologist. His medical education includes
the Chung-Ang University, College of Medicine, Seoul, Korea and residency at Michigan
State University. He did a fellowship in Pediatric Hematology/Oncology, Texas
Children's Hospital.
Sutter Health Research Enterprise
5275 F Street
Sacramento, CO, 95819
(916) 733-1757
simr@sutterhealth.org
Primary Research Interests
Related Clinical Trials
Pediatric B-cell Acute Lymphoblastic Leukemia (COG_AALL1331)
Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic
Leukemia
Investigators: Saunders C. Hsu M.D, YiSheng Lee M.D., Yung Soon Yim MD
Status: Active, Not Recruiting
Pediatric B-Lymphoblastic Leukemia (COG_AALL1731)
Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic
Leukemia
Investigator: Yung Soon Yim MD
Status: Active, Recruiting
Pediatric Cancer (COG_APEC14B1)
Project: Every Child for Younger Patients With Cancer
Investigators: Saunders C. Hsu M.D, YiSheng Lee M.D., Yung Soon Yim MD
Status: Active, Recruiting
Pediatric Ependyoma (COG_ACNS0831)
Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation
Therapy in Treating Patients With Newly Diagnosed Ependymoma
Investigators: Saunders C. Hsu M.D, YiSheng Lee M.D., Yung Soon Yim MD
Status: Active, Not Recruiting
Pediatric Hodgkin Lymphoma (COG_AHOD1331)
Brentuximab Vedotin and Combination Chemotherapy in Treating Children and Young Adults
With Stage IIB or Stage IIIB-IVB Hodgkin Lymphoma
Investigators: Saunders C. Hsu M.D, YiSheng Lee M.D., Yung Soon Yim MD
Status: Active, Not Recruiting
Pediatric Leukemia (COG_AALL1131)
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk
B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations
Investigators: Saunders C. Hsu M.D, YiSheng Lee M.D., Yung Soon Yim MD
Status: Active, Not Recruiting
Pediatric Neuroblastoma (COG ANBL00B1)
Combination Chemotherapy and Surgery With or Without Isotretinoin in Treating Young
Patients With Neuroblastoma
Investigators: Saunders C. Hsu M.D, YiSheng Lee M.D., Yung Soon Yim MD
Status: Active, Recruiting
Pediatric Neuroblastoma (COG_ANBL1232)
Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients
With Non-high Risk Neuroblastoma
Investigators: Saunders C. Hsu M.D, YiSheng Lee M.D., Yung Soon Yim MD
Status: Active, Recruiting